| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Ovarian Cancer | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Ovarian Neoplasms | |||||
| 3 | More general conditions related to this trial | ||||
| Adnexal Diseases | |||||
| Endocrine Gland Neoplasms | |||||
| Endocrine System Diseases | |||||
| Genital Diseases, Female | |||||
| Genital Neoplasms, Female | |||||
| Gonadal Disorders | |||||
| Neoplasms | |||||
| Neoplasms by Site | |||||
| Ovarian Diseases | |||||
| Urogenital Neoplasms | |||||
| 4 | Interventions listed in this trial | ||||
| toremifene | |||||
| 5 | More general drug interventions related to this trial | ||||
| Antineoplastic Agents | |||||
| Antineoplastic Agents, Hormonal | |||||
| Bone Density Conservation Agents | |||||
| Estrogen Receptor Modulators | |||||
| Hormone Antagonists | |||||
| Hormones, Hormone Substitutes, and Hormone Antagonists | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Selective Estrogen Receptor Modulators | |||||
| Therapeutic Uses | |||||
| 6 | Sponsors listed in this trial | ||||
| George Washington University | |||||
|
